Skip to main content
SpringerLink
Log in

Type 2 Diabetes in Ethnic Minority Groups in Europe

  • Chapter
  • First Online:
Ethnic Diversities, Hypertension and Global Cardiovascular Risk

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

  • 388 Accesses

Abstract

Type 2 diabetes (T2D) is well established as an important risk factor for cardiovascular disease. The global burden of T2D is increasing rapidly, in particular, in low- and middle-income countries. Ethnic minority groups in Europe are up to four times more likely to be affected by T2D compared to Europeans and are also disproportionally affected compared to their compatriots in their countries of origin. The reasons for this disproportionate burden are unclear but are believed to be an interplay between genetic and environmental factors. The underlying pathophysiology of T2D seems to differ between ethnic groups, with most ethnic minority groups having higher insulin resistance compared to Europeans even in a normoglycaemic state. Furthermore, while obesity is an important determinant of T2D across ethnic groups, higher levels of obesity in ethnic minority groups only explain part of their higher T2D burden. Health-related behaviours such as diet and physical activity can contribute to T2D among ethnic minority groups either mediated via obesity or directly. Few genetic factors have been identified that may predispose ethnic minority groups to T2D, but more diversity in genetics research is needed to get a better picture of genetic predispositions for T2D among ethnic minority groups. In the meantime, adaptation of population-based lifestyle interventions to ethnic minority groups, and evaluation of these interventions, is crucial to curb the rise of T2D among ethnic minority groups. Early detection is essential for prevention of micro- and macrovascular complications contributing to cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.

    Article  PubMed Central  CAS  Google Scholar 

  2. Stamler J, Vaccaro O, Neaton JD, Wentworth D, Group MRFITR. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434–44.

    Article  CAS  PubMed  Google Scholar 

  3. Morrish NJ, Wang S-L, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(2):S14.

    Article  PubMed  Google Scholar 

  4. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421–31.

    Article  CAS  PubMed  Google Scholar 

  5. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–81.

    Article  CAS  PubMed  Google Scholar 

  6. World Health Organization (WHO). Global report on diabetes. 2016.

    Google Scholar 

  7. Gholap N, Davies M, Patel K, Sattar N, Khunti K. Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes. 2011;5(1):45–56.

    Article  PubMed  Google Scholar 

  8. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40.

    Article  CAS  PubMed  Google Scholar 

  9. International Diabetes Federation (IDF). IDF diabetes atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.

    Google Scholar 

  10. International Diabetes Federation (IDF). IDF diabetes atlas. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017.

    Google Scholar 

  11. International Diabetes Federation (IDF). IDF diabetes atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013. Report No.: 2930229853.

    Google Scholar 

  12. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for. Diabetes Res Clin Pract. 2035;103(2):137–49.

    Article  Google Scholar 

  13. Unwin N, James P, McLarty D, Machybia H, Nkulila P, Tamin B, et al. Rural to urban migration and changes in cardiovascular risk factors in Tanzania: a prospective cohort study. BMC Public Health. 2010;10(1):1.

    Article  Google Scholar 

  14. Misra A, Ganda OP. Migration and its impact on adiposity and type 2 diabetes. Nutrition. 2007;23(9):696–708.

    Article  PubMed  Google Scholar 

  15. Meeks KAC, Freitas-Da-Silva D, Adeyemo A, Beune EJAJ, Modesti PA, Stronks K, et al. Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Intern Emerg Med. 2016;11(3):327–40.

    Article  PubMed  Google Scholar 

  16. Snijder MB, Agyemang C, Peters RJ, Stronks K, Ujcic-Voortman JK, van Valkengoed IGM. Case finding and medical treatment of Type 2 diabetes among different ethnic minority groups: the HELIUS study. J Diabetes Res. 2017;2017:9896849.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med. 1998;15(1):53–9.

    Article  CAS  PubMed  Google Scholar 

  18. Patel D, Winterbotham M, Britt R, Sutton G, Bhatnagar D, Mackness MI, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet. 1995;345(8947):405–9.

    Article  PubMed  Google Scholar 

  19. Patel JV, Vyas A, Cruickshank JK, Prabhakaran D, Hughes E, Reddy KS, et al. Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis. 2006;185(2):297–306.

    Article  CAS  PubMed  Google Scholar 

  20. Gujral UP, Narayan KV, Pradeepa RG, Deepa M, Ali MK, Anjana RM, et al. Comparing type 2 diabetes, prediabetes, and their associated risk factors in Asian Indians in India and in the US: the CARRS and MASALA studies. Diabetes Care. 2015;38(7):1312–8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Agyemang C, Meeks K, Beune E, Owusu-Dabo E, Mockenhaupt FP, Addo J, et al. Obesity and type 2 diabetes in sub-Saharan Africans—is the burden in today’s Africa similar to African migrants in Europe? The RODAM study. BMC Med. 2016;14(1):166.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–83.

    Article  CAS  PubMed  Google Scholar 

  24. Haffner SM, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45(6):742–8.

    Article  CAS  PubMed  Google Scholar 

  25. Hasson BR, Apovian C, Istfan N. Racial/ethnic differences in insulin resistance and beta cell function: relationship to racial disparities in type 2 diabetes among African Americans versus Caucasians. Curr Obes Rep. 2015;4(2):241–9.

    Article  PubMed  Google Scholar 

  26. Joffe B, Panz V, Wing J, Raal F, Seftel H. Pathogenesis of non-insulin-dependent diabetes mellitus in the black population of southern Africa. Lancet. 1992;340(8817):460–2.

    Article  CAS  PubMed  Google Scholar 

  27. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and caucasians. J Clin Endocrinol Metab. 2001;86(11):5366–71.

    Article  CAS  PubMed  Google Scholar 

  28. Ehtisham S, Crabtree N, Clark P, Shaw N, Barrett T. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J Clin Endocrinol Metab. 2005;90(7):3963–9.

    Article  CAS  PubMed  Google Scholar 

  29. McKeigue P, Shah B, Marmot M. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337(8738):382–6.

    Article  CAS  PubMed  Google Scholar 

  30. Knight TM, Smith Z, Whittles A, Sahota P, Lockton JA, Hogg G, et al. Insulin resistance, diabetes, and risk markers for ischaemic heart disease in Asian men and non-Asian in Bradford. Br Heart J. 1992;67(5):343–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Osei K, Cottrell DA, Harris B. Differences in basal and poststimulation glucose homeostasis in nondiabetic first degree relatives of black and white patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 1992;75(1):82–6.

    CAS  PubMed  Google Scholar 

  32. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–34.

    Article  CAS  PubMed  Google Scholar 

  33. Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, et al. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab. 1991;73(4):866–76.

    Article  CAS  PubMed  Google Scholar 

  34. Meeks KA, Stronks K, Adeyemo A, Addo J, Bahendeka S, Beune E, et al. Peripheral insulin resistance rather than beta cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African individuals: findings from the RODAM study. Diabetologia. 2017;60(5):854–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gregg EW, Cheng YJ, Narayan KV, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med. 2007;45(5):348–52.

    Article  PubMed  Google Scholar 

  36. Seidell J. Time trends in obesity: an epidemiological perspective. Horm Metab Res. 1997;29(04):155–8.

    Article  CAS  PubMed  Google Scholar 

  37. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.

    Article  CAS  PubMed  Google Scholar 

  38. Wang Y, Beydoun MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29(1):6–28.

    Article  CAS  PubMed  Google Scholar 

  39. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002;51(4):1005–15.

    Article  CAS  PubMed  Google Scholar 

  40. Meeks KA, Stronks K, Beune EJ, Adeyemo A, Henneman P, Mannens MM, et al. Prevalence of type 2 diabetes and its association with measures of body composition among African residents in the Netherlands—the HELIUS study. Diabetes Res Clin Pract. 2015;110(2):137–46.

    Article  PubMed  Google Scholar 

  41. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes. 1997;46(3):456–62.

    Article  CAS  PubMed  Google Scholar 

  42. Mohan V, Sharp P, Cloke H, Burrin J, Schumer B, Kohner E. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia. 1986;29(4):235–7.

    Article  CAS  PubMed  Google Scholar 

  43. Heald A, Sharma R, Anderson S, Vyas A, Siddals K, Patel J, et al. Dietary intake and the insulin-like growth factor system: effects of migration in two related populations in India and Britain with markedly different dietary intake. Public Health Nutr. 2005;8(6):620–7.

    Article  CAS  PubMed  Google Scholar 

  44. Galbete C, Nicolaou M, Meeks KA, de-Graft Aikins A, Addo J, Amoah SK, et al. Food consumption, nutrient intake, and dietary patterns in Ghanaian migrants in Europe and their compatriots in Ghana. Food Nutr Res. 2017;61(1):1341809.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Dekker LH, van Dam RM, Snijder MB, Peters RJ, Dekker JM, De Vries JH, et al. Comparable dietary patterns describe dietary behavior across ethnic groups in the Netherlands, but different elements in the diet are associated with glycated hemoglobin and fasting glucose concentrations. J Nutr. 2015;145(8):1884–91.

    Article  CAS  PubMed  Google Scholar 

  46. Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis. Eur J Epidemiol. 2015;30(7):529–42.

    Article  PubMed  Google Scholar 

  47. Prior SJ, Blumenthal JB, Katzel LI, Goldberg AP, Ryan AS. Increased skeletal muscle capillarization after aerobic exercise training and weight loss improves insulin sensitivity in adults with IGT. Diabetes Care. 2014;37(5):1469–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Lip GY, Luscombe C, McCarry M, Malik I, Beevers G. Ethnic differences in public health awareness, health perceptions and physical exercise: implications for heart disease prevention. Ethn Health. 1996;1(1):47–53.

    Article  CAS  PubMed  Google Scholar 

  49. Lip GYH, Cader MZ, Lee F, Munir SM, Beevers DG. Ethnic differences in pre-admission levels of physical activity in patients admitted with myocardial infarction. Int J Cardiol. 1996;56(2):169–75.

    Article  CAS  PubMed  Google Scholar 

  50. Shaukat N, Douglas JT, Bennett JL, de Bono DP. Can physical activity explain the differences in insulin levels and fibrinolytic activity between young indo-origin and European relatives of patients with coronary artery disease? Fibrinolysis. 1995;9(1):55–63.

    Article  CAS  Google Scholar 

  51. Ujcic-Voortman JK, Schram MT, Jacobs-van der Bruggen MA, Verhoeff AP, Baan CA. Diabetes prevalence and risk factors among ethnic minorities. Eur J Pub Health. 2009;19(5):511–5.

    Article  Google Scholar 

  52. Burdett T (EBI) HPN, Hastings E (EBI), Hindorff LA (NHGRI), Junkins HA (NHGRI), Klemm AK (NHGRI), MacArthur J (EBI), Manolio TA (NHGRI), Morales J (EBI), Parkinson H (EBI) and Welter D (EBI). The NHGRI-EBI Catalog of published genome-wide association studies. 2017. www.ebi.ac.uk/gwas.

  53. Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature. 2016;538(7624):161.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N. Diabetes, genetics and ethnicity. Aliment Pharmacol Ther. 2005;22(s2):16–9.

    Article  PubMed  Google Scholar 

  55. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011;43(10):984–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Radha V, Vimaleswaran KS, Babu HNS, Abate N, Chandalia M, Satija P, et al. Role of genetic polymorphism peroxisome proliferator–activated receptor-γ2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and caucasian subjects. Diabetes Care. 2006;29(5):1046–51.

    Article  CAS  PubMed  Google Scholar 

  57. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;327(8489):1077–81.

    Article  Google Scholar 

  58. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595–601.

    Article  CAS  PubMed  Google Scholar 

  59. Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD, Hanson MA. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res. 2007;61:5R–10R.

    Article  PubMed  Google Scholar 

  60. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008;300(24):2886–97.

    Article  CAS  PubMed  Google Scholar 

  61. Roseboom TJ, Painter RC, van Abeelen AFM, Veenendaal MVE, de Rooij SR. Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas. 2011;70(2):141–5.

    Article  PubMed  Google Scholar 

  62. Lumey L, Stein A, Kahn H. Food restriction during gestation and impaired fasting glucose or glucose tolerance and type 2 diabetes mellitus in adulthood: evidence from the Dutch hunger winter families study. J Dev Orig Health Dis. 2009;1(S1):S164.

    Google Scholar 

  63. Vickers MH. Early life nutrition, epigenetics and programming of later life disease. Nutrients. 2014;6(6):2165–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Agyemang C, Beune EJAJ, Meeks KAC, Owusu-Dabo E, Agyei-Baffour P, Aikins A, et al. Rationale and cross-sectional study design of the research on obesity and type 2 diabetes among African migrants: the RODAM study. BMJ Open. 2014;4(3):e004877.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Meeks KAC, Henneman P, Venema A, Burr T, Galbete C, Danquah I, et al. An epigenome-wide association study in whole blood of measures of adiposity among Ghanaians: the RODAM study. Clin Epigenetics. 2017;9:103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  66. Taylor R. Type 2 diabetes etiology and reversibility. Diabetes Care. 2013;36(4):1047–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Rychetnik L, Hawe P, Waters E, Barratt A, Frommer M. A glossary for evidence based public health. J Epidemiol Community Health. 2004;58(7):538–45.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ. Obesity prevention: the case for action. Int J Obes Relat Dis. 2002;26(3):425–36.

    Article  CAS  Google Scholar 

  69. Mozaffarian D, Afshin A, Benowitz NL, Bittner V, Daniels SR, Franch HA, et al. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation. 2012;126(12):1514–63.

    Article  PubMed  Google Scholar 

  70. Admiraal WM, Vlaar EM, Nierkens V, Holleman F, Middelkoop BJ, Stronks K, et al. Intensive lifestyle intervention in general practice to prevent type 2 diabetes among 18 to 60-year-old South Asians: 1-year effects on the weight status and metabolic profile of participants in a randomized controlled trial. PLoS One. 2013;8(7):e68605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care. One-year follow-up of the finnish national diabetes prevention program (FIN-D2D). Diabetes Care. 2010;33(10):2146–51.

    Article  PubMed  PubMed Central  Google Scholar 

  72. World Health Organization (WHO). A guide for population-based approaches to increasing levels of physical activity; implementation of the WHO global strategy on diet physical activity and health. Geneva: World Health Organization; 2007.

    Google Scholar 

  73. Rutten G, De Grauw W, Nijpels G, Houweling S, Van de Laar F, Bilo H, et al. NHG-standaard diabetes mellitus type 2 (derde herziening). Huisarts en Wetenschap. 2013;56(10):512–25.

    Google Scholar 

  74. National Institute for Health and Care Excellence (NICE). Public health guideline. Type 2 diabetes: prevention in people at high risk. London: National Institute for Health and Care Excellence; 2012.

    Google Scholar 

  75. Negandhi PH, Ghouri N, Colhoun HM, Fischbacher CM, Lindsay RS, McKnight JA, et al. Ethnic differences in glycaemic control in people with type 2 diabetes mellitus living in Scotland. PLoS One. 2013;8(12):e83292.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Public Health, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands

    Karlijn A. C. Meeks & Charles Agyemang

Authors
  1. Karlijn A. C. Meeks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles Agyemang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles Agyemang .

Editor information

Editors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Florence, Firenze, Italy

    Pietro Amedeo Modesti

  2. University of Warwick, Warwick Medical School, and University, Hospitals Coventry and Warwickshire, NHS Trust, Coventry, UK

    Francesco P. Cappuccio

  3. Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy

    Gianfranco Parati

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Meeks, K.A.C., Agyemang, C. (2018). Type 2 Diabetes in Ethnic Minority Groups in Europe. In: Modesti, P., Cappuccio, F., Parati, G. (eds) Ethnic Diversities, Hypertension and Global Cardiovascular Risk. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-93148-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93148-7_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93147-0

  • Online ISBN: 978-3-319-93148-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation